Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Sunlei

(22,651 posts)
Sat Nov 7, 2015, 02:44 PM Nov 2015

Statement by MSF on the Official Release of the Full Text of the Trans-Pacific Partnership Trade Agr

Statement by MSF on the Official Release of the Full Text of the Trans-Pacific Partnership Trade Agreement

press release. November 05, 2015

The Trans-Pacific Partnership (TPP) is a trade agreement negotiated between the U.S. and eleven other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. After more than five years of negotiations conducted in secret without the opportunity for public review, the agreed text, which will now be submitted to national processes for final signature and ratification, has been officially and publicly released. Doctors Without Borders/Médecins Sans Frontières (MSF) remains extremely concerned about the inclusion of dangerous provisions that would dismantle public health safeguards enshrined in international law and restrict access to price-lowering generic medicines for millions of people.

MSF statement by Judit Rius Sanjuan, U.S. manager and legal policy advisor for MSF’s Access Campaign:

"MSF remains gravely concerned about the effects that the Trans-Pacific Partnership trade deal will have on access to affordable medicines for millions of people, if it is enacted. Today’s official release of the agreed TPP text confirms that the deal will further delay price-lowering generic competition by extending and strengthening monopoly market protections for pharmaceutical companies.

The TPP is a bad deal for medicine: it’s bad for humanitarian medical treatment providers such as MSF, and it’s bad for people who need access to affordable medicines around the world, including in the United States.
At a time when the high price of life-saving medicines and vaccines is increasingly recognized as a barrier to effective medical care, it is very concerning to see that the U.S. government and pharmaceutical companies have succeeded in locking in rules that will keep medicine prices high for longer and limit the tools that governments and civil society have to try to increase generic competition.

For example, if enacted, the TPP will not allow national regulatory authorities to use existing data that demonstrates a biological product’s safety and efficacy to authorize the sale of competitor products, even in the absence of patents. The TPP would also force governments to extend existing patent monopolies beyond current 20-year terms at the request of pharmaceutical companies, and to redefine what type of medicine deserves a patent, including mandating the granting of new patents for modifications of existing medicines.

The provisions in the TPP text will not only raise the price of medicines and cause unnecessary suffering, but they also represent a complete departure from the U.S. government’s previous commitments to global health, including safeguards included in the U.S.’s 2007 ‘New Trade Policy.’

It is not too late to prevent further restrictions on access to affordable medicines in the TPP. As the text now goes to national legislatures for final approval, we urge all TPP governments to carefully consider whether the agreed TPP text reflects the direction they want to take on access to affordable medicines and promotion of biomedical innovation; if it does not, the TPP should be modified or rejected.”

http://www.doctorswithoutborders.org/article/statement-msf-official-release-full-text-trans-pacific-partnership-trade-agreement
2 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Statement by MSF on the Official Release of the Full Text of the Trans-Pacific Partnership Trade Agr (Original Post) Sunlei Nov 2015 OP
The more I read about it the worse this thing gets lindysalsagal Nov 2015 #1
I think the USA will always have medicine price gougers. A positive is DWB asks all the signers Sunlei Nov 2015 #2

lindysalsagal

(20,692 posts)
1. The more I read about it the worse this thing gets
Sun Nov 8, 2015, 03:21 PM
Nov 2015

And Hillary's all for it. Nowhere to run.

Maybe the GOP is discintigrating because the dems have stolen their purposes and practices, and they're redundant.

Sunlei

(22,651 posts)
2. I think the USA will always have medicine price gougers. A positive is DWB asks all the signers
Sun Nov 8, 2015, 03:45 PM
Nov 2015
The TPP is a bad deal for medicine: it’s bad for humanitarian medical treatment providers such as MSF, and it’s bad for people who need access to affordable medicines around the world, including in the United States.
At a time when the high price of life-saving medicines and vaccines is increasingly recognized as a barrier to effective medical care, it is very concerning to see that the U.S. government and pharmaceutical companies have succeeded in locking in rules that will keep medicine prices high for longer and limit the tools that governments and civil society have to try to increase generic competition.

For example, if enacted, the TPP will not allow national regulatory authorities to use existing data that demonstrates a biological product’s safety and efficacy to authorize the sale of competitor products, even in the absence of patents. The TPP would also force governments to extend existing patent monopolies beyond current 20-year terms at the request of pharmaceutical companies, and to redefine what type of medicine deserves a patent, including mandating the granting of new patents for modifications of existing medicines.
Latest Discussions»General Discussion»Statement by MSF on the O...